A new link between Fanconi anemia and human papillomavirus-associated malignancies

Journal of the National Cancer Institute

Volumn 95, Issue 22, 2003, Pages 1648-1650

  Lowy, Douglas R ^a   Gillison, Maura L ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEIN P53; VIRUS DNA; VIRUS VACCINE;

ANUS CANCER; AUTOSOMAL RECESSIVE DISORDER; BONE MARROW TRANSPLANTATION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CLINICAL TRIAL; DISEASE ASSOCIATION; EDITORIAL; EPIDERMODYSPLASIA VERRUCIFORMIS; FANCONI ANEMIA; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENITAL TRACT CANCER; HEAD AND NECK CARCINOMA; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR GENETICS; MOUTH CANCER; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; VIRUS INFECTION; VULVA CANCER; WART VIRUS;

EID: 0344237142     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djg125     Document Type: Editorial

References (27)

1. Kutler DI, Wreesmann VB, Goberdhan A, Ben-Porat L, Satagopan J, Ngai I, et al. Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst 2003; 95:1718-21.
2. Alter BP. Fanconi's anemia and malignancies. Am J Hematol 1996;53:99-110.
3. Alter BP. Cancer in Fanconi anemia, 1927-2001. Cancer 2003;97:425-40.
4. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003;101:822-6.
5. Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 2003;101:1249-56.
6. Kutler DI, Auerbach AD, Satagopan J, Giampietro PF, Batish SD, Huvos AG, et al. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg 2003; 129:106-12.
7. Gillison ML, Shah KV. Chapter 9: Role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr 2003;(31):57-65.
8. Herrero R. Chapter 7: Human papillomavirus and cancer of the upper aerodigestive tract. J Natl Cancer Inst Monogr 2003;(31):47-51.
9. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-20.
10. Tommasino M, Accardi R, Caldeira S, Dong W, Malanchi I, Smet A, et al. The role of TP53 in cervical carcinogenesis. Hum Mutat 2003;21:307-12.
11. Majewski S, Jablonska S, Orth G. Epidermodysplasia verruciformis. Immunological and nonimmunological surveillance mechanisms: role in tumor progression. Clin Dermatol 1997;15:321-34.
12. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 2002;32:579-81.
13. Bogliolo M, Cabre O, Callen E, Castillo V, Creus A, Marcos R, et al. The Fanconi anaemia genome stability and tumour suppressor network. Mutagenesis 2002;17:529-38.
14. D'Andrea AD. The Fanconi road to cancer. Genes Dev 2003;17:1933-6.
15. Lowy DR, Howley PH. Papillomaviruses. In: Fields BN, Knipe DM, Howley PH, Chanock RM, Monath TP, Melnick JL, et al., editors. Fields virology. Vol 2. 4th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2001. p. 2231-64.
16. Munger K. The role of human papillomaviruses in human cancers. Front Biosci 2002;7:d641-9.
17. Palefsky JM, Holly EA. Chapter 6: Immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr 2003;(31):41-6.
18. Freie BW, Li X, Ciccone SL, Nawa K, Cooper S, Vogelweid C, et al. Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis. (July 10, 2003). Blood (DOI: 10.1182/blood-2003-03-0971).
19. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998;393:229-34.
20. Summersgill KF, Smith EM, Kirchner HL, Haugen TH, Turek LP. p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90: 334-9.
21. Kreimer AR, Alberg AJ, Daniel R, Gravitt PE, Viscidi R, Garrett ES, et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis. In press 2003.
22. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347:1645-51.
23. Lowy DR, Frazer IH. Chapter 16: Prophylactic human papillomavirus vaccines. J Natl Cancer Inst Monogr 2003;(31):111-6.
24. Miller CS, White DK. Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma: a retrospective review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:57-68.
25. Duensing S, Munger K. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res 2002;62:7075-82.
26. Riley RR, Duensing S, Brake T, Munger K, Lambert PF, Arbeit JM. Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Res 2003;63:4862-71.
27. Wang SS, Hildesheim A. Chapter 5: Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr 2003;(31):35-40.